Organ motion, set-up variation and treatment margins in radical radiotherapy of urinary bladder cancer

Radiotherapy and Oncology

Volumn 69, Issue 3, 2003, Pages 291-304

  Muren, Ludvig Paul ^a,b   Smaaland, Rune ^a   Dahl, Olav ^b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Internal margins; Organ motion; Set up margins; Set up uncertainty; Urinary bladder cancer

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER; BLADDER CANCER; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIGITALIZATION; ELECTRONICS; EMPIRICISM; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE RECONSTRUCTION; INTESTINE; MALE; MOTION; ORGAN SIZE; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION MEASUREMENT; RADIOGRAPHY; RECTUM; SAFETY; THREE DIMENSIONAL IMAGING; TREATMENT PLANNING; VARIANCE;

EID: 0344872657     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(03)00246-9     Document Type: Article

References (42)

1. Aaltonen P., Brahme A., Lax I., et al. Specification of dose delivery in radiation therapy. Recommendations by the Nordic Association of Clinical Physics (NACP). Acta Oncol. 36:1997;1-32.
2. Awwad H.K., Khalil E., Zikri A. The possibility of bladder preservation (BP) in the radical treatment of a mixed group of transitional and squamous cell bladder cancer: A phase II study (abstr). Radiother Oncol. 56:2000;S13.
3. Battermann J.J., Hart G.A.M., Breur K. Dose-effect relations for tumour control and complication rate after fast neutron therapy for pelvic tumours. Br J Radiol. 54:1981;899-904.
4. Boersma L.J., van den Brink M., Bruce A.M., et al. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys. 41:1998;83-92.
5. Dahl O., Kardamakis D., Lind B., Rosenwald J.C. Current status of conformal radiotherapy. Acta Oncol. 35:1996;41-57.
6. Dale E., Olsen D.R., Fosså S.D. Normal tissue complication probabilities correlated with late effects in the rectum after prostate conformal radiotherapy. Int J Radiat Oncol Biol Phys. 43:1999;385-391.
7. Dawson L.A., Mah K., Franssen E., Morton G. Target position variability throughout prostate radiotherapy. Int J Radiat Oncol Biol Phys. 42:1998;1155-1161.
8. Duncan W., Williams J.R., Kerr G.R., et al. An analysis of the radiation related morbidity observed in a randomized trial of neutron therapy for bladder cancer. Int J Radiat Oncol Biol Phys. 12:1986;2085-2092.
9. Dunst J., Rodel C., Zietman A., Schrott K.M., Sauer R., Shipley W.U. Bladder preservation in muscle-invasive bladder cancer by conservative surgery and radiochemotherapy. Semin Surg Oncol. 20:2001;24-32.
10. Eilertsen, K. An object oriented approach to radiotherapy image registration, storage and communication. Proceedings of the 5th International Workshop on Electronic Portal Imaging. 1998. Phoenix, Arizona.
11. Giovinazzo G., Arcangeli G., Tirindelli Danesi D., Saracino B., Cruciani E. Organ preservation in muscle infiltrating bladder cancer by concomitant chemoradiation (abstr). Radiother Oncol. 56:2000;S13.
12. Gospodarowicz M.K., Rider W.D., Keen C.W., et al. Bladder cancer: Long-term follow-up results of patients treated with radical radiation. Clin Oncol. 3:1991;155-161.
13. Harris S.J., Buchanan R.B. An audit and evaluation of bladder movements during radical radiotherapy. Clin Oncol (R Coll Radiol). 10:1998;262-264.
14. Hurkmans C.W., Remeijer P., Lebesque J.V., Mijnheer B.J. Set-up verification using portal imaging; review of current clinical practice. Radiother Oncol. 58:2001;105-120.
15. ICRU, Report 62: Prescribing, recording and reporting photon beam therapy (supplement to ICRU report 50). Bethesda: International Commission on Radiation Units and Measurements. 1999.
16. Jackson A., Skwarchuk M.W., Zelefsky M.J., et al. Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms. Int J Radiat Oncol Biol Phys. 49:2001;685-698.
17. Lebesque J.V., Bruce A.M., Kroes A.P., Touw A., Shouman R.T., van Herk M. Variation in volumes, dose-volume histograms, and estimated normal tissue complication probabilities of rectum and bladder during conformal radiotherapy of T3 prostate cancer. Int J Radiat Oncol Biol Phys. 33:1995;1109-1119.
18. Mackie T.R., Balog J., Ruchula K., et al. Tomotherapy. Semin Radiat Oncol. 9:1999;108-117.
19. McKenzie A., van Herk M., Mijnheer B. Margins for geometric uncertainty around organs at risk in radiotherapy. Radiother Oncol. 62:2002;299-307.
20. McKenzie A.L., van Herk M., Mijnheer B. The width of margins in radiotherapy treatment plans. Phys Med Biol. 45:2000;3331-3342.
21. Meijer G.J., Rasch C., Remeijer P., Lebesque J.V. 3D analysis of delineation errors, setup errors and organ motion during radiation therapy of bladder cancer. Int J Radiat Oncol Biol Phys. 55:2003;1277-1287.
22. Morrison R. The results of treatment of cancer of the bladder - a clinical contribution to radiobiology. Clin Radiol. 26:1975;67-75.
23. Mubata C.D., Bidmead A.M., Ellingham L.M., Thompson V., Dearnaley D.P. Portal imaging protocol for radical dose-escalated radiotherapy treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 40:1998;221-231.
24. Muren L.P., Hafslund R., Gustafsson A., Smaaland R., Dahl O. Partially wedged beams improve radiotherapy treatment of urinary bladder cancer. Radiother Oncol. 59:2001;21-30.
25. Muren L.P., Hafslund R., Murman A., Valen H., Dahl O. Partially wedged radiation beams. Med Phys. 27:2000;527-534.
26. Quilty P.M., Duncan W. Primary radical radiotherapy for T3 transitional cell cancer of the bladder: An analysis of survival and control. Int J Radiat Oncol Biol Phys. 12:1986;853-860.
27. Remeijer P., Geerlof E., Ploeger L., Gilhuijs K., van Herk M., Lebesque J.V. 3-D portal image analysis in clinical practice: an evaluation of 2-D and 3-D analysis techniques as applied to 30 prostate cancer patients. Int J Radiat Oncol Biol Phys. 46:2000;1281-1290.
28. Rodel C., Grabenbauer G.G., Kuhn R., et al. Organ preservation in patients with invasive bladder cancer: initial results of an intensified protocol of transurethral surgery and radiation therapy plus concurrent cisplatin and 5-fluorouracil. Int J Radiat Oncol Biol Phys. 52:2002;1303-1309.
29. Roeske J.C., Forman J.D., Mesina C.F., et al. Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapy. Int J Radiat Oncol Biol Phys. 33:1995;1321-1329.
30. Salminen E. External beam radiation treatment of urinary bladder carcinoma. An analysis of results in 203 patients. Acta Oncol. 29:1990;909-914.
31. Skolysewski J., Reinfuss M., Weiss M. Radical external beam radiotherapy of urinary bladder carcinoma. An analysis of results in 500 patients. Acta Oncol. 33:1994;561-565.
32. Skwarchuk M.W., Jackson A., Zelefsky M.J., et al. Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response. Int J Radiat Oncol Biol Phys. 47:2000;103-113.
33. Smaaland R., Akslen L.A., Tønder B., Mehus A., Lote K., Albrektsen G. Radical radiation treatment of invasive and locally advanced bladder carcinoma in elderly patients. Br J Urol. 67:1991;61-69.
34. Stroom J.C., de Boer H.C., Huizenga H., Visser A.G. Inclusion of geometrical uncertainties in radiotherapy treatment planning by means of coverage probability. Int J Radiat Oncol Biol Phys. 43:1999;905-919.
35. Suit H.D., Westgate S.J. Impact of improved local control on survival. Int J Radiat Oncol Biol Phys. 12:1986;453-458.
36. Sur R.K., Clinkard J., Jones W.G., et al. Changes in target volume during radiotherapy treatment of invasive bladder carcinoma. Clin Oncol. 5:1993;30-33.
37. Tait D.M., Nahum A.E., Meyer L.C., et al. Acute toxicity in pelvic radiotherapy; a randomised trial of conformal versus conventional treatment. Radiother Oncol. 42:1997;121-136.
38. Turner S.L., Swindell R., Bowl N., et al. Bladder movement during radiotherapy for bladder cancer: implications for treatment planning. Int J Radiat Oncol Biol Phys. 39:1997;355-360.
39. van Herk M., Bruce A., Guus Kroes A.P., Shouman T., Touw A., Lebesque J.V. Quantification of organ motion during conformal radiotherapy of the prostate by three dimensional image registration. Int J Radiat Oncol Biol Phys. 33:1995;1311-1320.
40. van Herk M., Remeijer P., Rasch C., Lebesque J.V. The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys. 47:2000;1121-1135.
41. Zapatero A., Martin de Vidales C., Marin A., et al. Invasive bladder cancer: a single-institution experience with bladder-sparing approach. Int J Cancer. 90:2000;287-294.
42. Zouhair A., Ozsahin M., Schneider D., et al. Invasive bladder carcinoma: a pilot study of conservative treatment with accelerated radiotherapy and concomitant cisplatin. Int J Cancer. 96:2001;350-355.